Topic: Multiple Myeloma.
Destination: Pfizer launches a call for funding for projects that promote the quality of care and best practices around the treatment of patients with relapsed/refractory Multiple Myeloma receiving treatment with a biospecific antibody.
Budget: 250,000€/project.
Duration: Maximum 2 years.
Llena el siguiente formulario para recibir más información: